Literature DB >> 14260376

NORADRENALINE STORES IN NERVE TERMINALS OF THE SPLEEN: CHANGES DURING HEMORRHAGIC SHOCK.

A B DAHLSTROEM, B E ZETTERSTROEM.   

Abstract

In dogs subjected to hemorrhagic shock, a marked decrease in the noradrenaline content of the sympathetic nerve terminals in the normally innervated spleen is revealed by means of a histochemical fluorescence method. Deprivation of the sympathetic impulse-flow to the tissue immediately before the animals are subjected to shock prevents this depletion. The results support the hypothesis that the vasoconstriction which occurs during shock is due to the effect of noradrenaline released locally in the tissues, and not to circulating noradrenaline.

Entities:  

Keywords:  DENERVATION; DOGS; EXPERIMENTAL LAB STUDY; FLUORESCENCE; HISTOCYTOCHEMISTRY; MUSCLE, SMOOTH; NERVE ENDINGS; NEUROCHEMISTRY; NOREPINEPHRINE; SHOCK, HEMORRHAGIC; SPLEEN; SYMPATHETIC NERVOUS SYSTEM; VASOMOTOR SYSTEM

Mesh:

Substances:

Year:  1965        PMID: 14260376     DOI: 10.1126/science.147.3665.1583

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Rhythmic activity of the isolated spleen during longterm perfusion.

Authors:  R Pabst; F Trepel
Journal:  Experientia       Date:  1974-08-15

2.  Morphology and distribution of intrinsic adrenergic neurones in the proximal colon of the guinea-pig.

Authors:  J B Furness; M Costa
Journal:  Z Zellforsch Mikrosk Anat       Date:  1971

Review 3.  Innervation and vascular pharmacodynamics of the mammalian spleen.

Authors:  F D Reilly
Journal:  Experientia       Date:  1985-02-15

4.  Electron microscopic studies of the innervation of the human spleen.

Authors:  U Heusermann; H J Stutte
Journal:  Cell Tissue Res       Date:  1977-10-26       Impact factor: 5.249

5.  The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog.

Authors:  R Corder; P J Lowry; P G Withrington
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.